long term glp 1 GLP-1 Drugs Offer Obesity Treatment But Raise Key Concerns Rethinking GLP-1s: A Smarter Policy

Numerous other trials have demonstrated positive cardiovascular outcomes with focus on HFpEF in the SUMMIT trial for tirzepatide and the STEP-HFpEF trial for semaglutide [50,51,52]

Remember: Use the TRICARE Formulary Search Tool to check costs and coverage requirements

Vaquer-Alicea J, Diamond MI (2019) Propagation of protein aggregation in neurodegenerative diseases

Cost is the primary barrier, with insurance companies covering diabetes medications more readily than weight-loss prescriptions, even when the same drug treats both conditions

By periodically testing ones glomerular filtration rate , creatinine , and cystatin-C , declining kidney function can be identified in time to initiate preventive measures